What are we, 15m EV + $11m cash, upcoming trials and newsflow...

What are we, 15m EV + $11m cash, upcoming trials and newsflow and a strategic approach to monetise / derisk early (post P1). In a roaring small cap / bio tech market this would be +50c (we have been near there previously and we are far more progressed since those prices). Sentiment for the sector is completely shot .. does this = buying opportunity if you can ride out the next 6months , id think so. I havent topped up for a while (since 21c) as have focused spare funds in other places and am already holding more than I should but am very tempted to add more here... In at about 27c so wont take much to be in the green. GLTAH.